Capricor Therapeutics, Inc. Gains 371.07%
Wed, Dec 03, 2025 at 07:41 PM
Capricor Therapeutics, Inc. (CAPR:NASDAQ) shot up at $29.96, a gain of 371.1%. On Wed, Dec 03, 2025, CAPR:NASDAQ hit a New 2-Week High of $29.96. The stock appeared on our News Catalysts scanner on Wed, Dec 03, 2025 at 12:39 PM in the 'BIOTECH' category. From Wed, Nov 19, 2025, the stock recorded 55.56% Up Days and 60.00% Green Days
The stock spiked on Wed, Dec 03, 2025 at $40.37 with a volume of 56M+.
About Capricor Therapeutics, Inc. (CAPR:NASDAQ)
Capricor Therapeutics Inc is a clinical stage biotechnology company developing products for the treatment of cardiovascular diseases with a focus on heart failure.
Top 10 Gainers:
- Smart for Life, Inc. (SMFL:NASDAQ), 1780%
- Capricor Therapeutics, Inc. (CAPR:NASDAQ), 371.07%
- Nauticus Robotics, Inc. (KITT:NASDAQ), 115.89%
- Virax Biolabs Group Limited (VRAX:NASDAQ), 75.11%
- iRobot Corporation (IRBT:NASDAQ), 73.85%
- Micropolis Holding Company (MCRP:NYSEMKT), 51.28%
- Q/C Technologies Inc Com Par $0.001 (QCLS:NASDAQ), 38.17%
- Kaixin Holdings (KXIN:NASDAQ), 33.87%
- Kazia Therapeutics Limited (KZIA:NASDAQ), 31.71%
- MapLight Therapeutics Inc. (MPLT:NASDAQ), 31.26%